Alerts will be sent to your verified email
Verify Email
BIOGEN
|
Biogen Pharmachem
|
Amrapali Industries
|
Cerebra Integ. Tech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.21 % | 2.68 % | -1.34 % |
|
5yr Avg Net Profit Margin
|
-19.83 % | 0.0 | -13.9 % |
|
Price to Book
|
0.87 | 2.45 | 0.49 |
|
P/E
|
66.23 | 45.79 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.2 Days | 765.04 Days |
|
5yr Average Interest Coverage Ratio
|
902.8 | 1.17 | 1.54 |
|
5yr Avg ROCE
|
0.21 % | 21.59 % | 3.66 % |
|
5yr Avg Operating Profit Margin
|
-19.88 % | 0.02 % | -2.53 % |
|
5 yr average Debt to Equity
|
0.0 | 2.08 | 0.11 |
|
5yr CAGR Net Profit
|
n/a | 14.37 % | n/a |
|
5yr Average Return on Assets
|
0.21 % | 0.61 % | -0.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 73.43 % | 0.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -4.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Biogen Pharmachem
|
Amrapali Industries
|
Cerebra Integ. Tech
|
|---|